The global multiplex assays market is expected to reach $6.24 billion by 2030, driven by the preference for multiplex assays over singleplex varieties and…
Browsing: flow cytometry
This article discusses the use of flow cytometry MRD (minimal residual disease) testing for detecting impending relapse in patients with acute myeloid leukemia (AML).…
The global flow cytometry market is projected to achieve a remarkable compound annual growth rate (CAGR) of 9.2% over the forecast period, driven by…